Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lucy F. Chen"'
Autor:
Benoit Baron, Hiroyoshi Suzuki, Kazuo Nishimura, Go Kimura, Andrew J. Armstrong, Brad Rosbrook, Taro Iguchi, Arnulf Stenzl, Hiroji Uemura, Lucy F. Chen, Futoshi Kunieda, Satoshi Fukasawa, Jennifer Sugg, Hiroaki Matsumoto, Akira Yokomizo
Publikováno v:
Int J Urol
International Journal of Urology
International Journal of Urology
Objective To evaluate the efficacy and safety of enzalutamide plus androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer. Methods A post-hoc analysis of the Japanese subgroup in the phase III, randomized, mult
Autor:
Jeffrey M. Holzbeierlein, Taro Iguchi, Russell Z. Szmulewitz, Benoit Baron, Andrew J. Armstrong, Neal D. Shore, Daniel P. Petrylak, Boris Alekseev, Jennifer Sugg, Arnulf Stenzl, Brad Rosbrook, Arnauld Villers, Arun Azad, Antonio Alcaraz, Lucy F. Chen
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Oncology
Universidad de Barcelona
Journal of Clinical Oncology
PURPOSE Enzalutamide, a potent androgen-receptor inhibitor, has demonstrated significant benefits in metastatic and nonmetastatic castration-resistant prostate cancer. We evaluated the efficacy and safety of enzalutamide in metastatic hormone-sensiti
Publikováno v:
Future Oncology. 12:2669-2672
American Society of Clinical Oncology Annual Meeting, Chicago, IL, USA, 3–7 June 2016 The American Society of Clinical Oncology Annual Meeting took place in Chicago, IL, USA, from 3 to 7 June 2016. Over 30,000 oncologists, researchers, related prof
Autor:
Mitchell C. Posner, A. Parekh, Paul Roach, Nikolai N. Khodarev, Lucy F. Chen, Sean P. Pitroda, Gene Fu Liu, Xiaona Huang, Melinda E. Stack, Hua Liang, Sui Sui Song, Ralph R. Weichselbaum
Publikováno v:
Molecular cancer therapeutics. 17(4)
Lung cancer is the leading cause of cancer-related deaths worldwide. Approximately 85% of all lung cancers are non–small cell histology [non–small cell lung cancer (NSCLC)]. Modern treatment strategies for NSCLC target driver oncogenes and immune
Autor:
Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Boris Alekseev, Andrew J. Armstrong, Antonio Alcaraz, Arun Azad, Taro Iguchi, Benoit Baron, Arnulf Stenzl, Neal D. Shore, Lucy F. Chen, Brad Rosbrook, Arnauld Villers
Publikováno v:
Journal of Clinical Oncology. 37:5048-5048
5048 Background: ENZA has demonstrated benefit in men with metastatic and nonmetastatic castration-resistant prostate cancer (CRPC). ARCHES assessed the efficacy of ENZA with ADT in men with mHSPC, including pre-specified subgroups based on prior the
Autor:
Benoit Baron, Boris Alekseev, Russell Z. Szmulewitz, Brad Rosbrook, Arnauld Villers, Jennifer Sugg, Antonio Alcaraz, Daniel P. Petrylak, Andrew J. Armstrong, Lucy F. Chen, Arnulf Stenzl, Taro Iguchi, Neal D. Shore, Arun Azad
Publikováno v:
Journal of Clinical Oncology. 37:687-687
687 Background: ENZA, a potent androgen receptor inhibitor, has demonstrated benefit in men with metastatic and nonmetastatic castration-resistant prostate cancer (CRPC). Efficacy of ENZA with ADT in men with mHSPC is unknown. Methods: ARCHES is a mu
Autor:
Howard J. Halpern, Gene Fu F. Liu, Lucy F. Chen, Hongyuan Cao, Antonia Kolokythas, Barry L. Wenig, Michael T. Spiotto, Stephanie Ard, Mark C. Ranck, Ralph R. Weichselbaum, Abhishek A. Solanki
Publikováno v:
Cancer. 120:244-252
BACKGROUND Although black patients experience worse outcomes after treatment for squamous cell carcinoma of the head and neck (HNSCC), these conclusions were based on populations in which blacks comprised a minority of patients. The objective of the
Autor:
Kent Hoskins, Caryn E. Peterson, Sally Freels, Lucy F. Chen, Faith G. Davis, Shaveta Khosla, Charlotte E. Joslin, Marian L. Fitzgibbon
Publikováno v:
Journal of cancer research and clinical oncology. 142(8)
Head and neck squamous cell carcinoma (HNSCC) incidence is increasing, and evidence suggests survival disparities between non-Hispanic (nH) black and white males. However, temporal changes in HNSCCs and factors contributing to survival differences ha
Publikováno v:
Clinical Cancer Research. 16:2489-2495
The epidermal growth factor receptor (EGFR) is a validated target in squamous cell carcinoma of the head and neck (HNSCC). However, despite high expression of EGFR in these cancers, EGFR inhibitor monotherapy has only had modest activity. Potential m
Autor:
Lucy F. Chen, Gowri Ramadas
Publikováno v:
Lip Cancer ISBN: 9783642381799
Lip cancer is a rare type of oral cancer, mostly comprised of squamous cell carcinoma but can also include basal cell carcinoma, adenocarcinoma, and mucoepidermoid carcinoma of salivary glands. It accounts for approximately 25 % of all oral cavity ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d8c3359b9d70c7d3b31a74afe84d5d3
https://doi.org/10.1007/978-3-642-38180-5_7
https://doi.org/10.1007/978-3-642-38180-5_7